Cruse Michael (CIK 0001854179)

Latest company ownership

Shares held
49,455
Last filed at
Dec 13, 2022
Confidence Score
50.0
2025Q4
Confidence Score History
2021Q3 2025Q4

Recent buy/sell transactions

Exec date Filing date Company Role Signal Confidence Shares % of shares Under plan? Amount (USD)
Sep 1, 2022 Sep 2, 2022 OnKure Therapeutics, Inc. COO Buy 91.3 +7,500 19.76% $25.4K
Aug 29, 2022 Aug 31, 2022 OnKure Therapeutics, Inc. COO Buy 91.3 +7,255 23.63% $23.2K
Aug 25, 2021 Aug 26, 2021 OnKure Therapeutics, Inc. Senior VP-Corporate Operations Buy 91.3 +2,500 100.00% $18.6K